Finance

Beta
Lists
YPHDF:OTCMKTS
Ypsomed Holding AG
$354.92
0.00%
(0.00) 1D
Apr 6, 11:12:23 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for YPHDF...
Mkt. cap
4.63B
Avg. vol.
0.00
Volume
0.00
52-wk high
$535.75
52-wk low
$354.92
Shares outstanding
13.65M
No. of employees
2K
Mkt. cap
4.63B
Avg. vol.
0.00
Volume
0.00
52-wk high
$535.75
52-wk low
$354.92
Shares outstanding
13.65M
No. of employees
2K
News stories
From sources across the web
Profile
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology. Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
About Ypsomed Holding AG
CEOSimon Michel
Employees2.02K
Founded2003
Headquarters-
SectorMedical device
Websiteypsomed.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
181.34M
181.34M
184.15M
184.15M
Cost of goods sold
106.24M
106.24M
101.94M
101.94M
Cost of revenue
106.24M
106.24M
101.94M
101.94M
Research and development expenses
9.44M
9.44M
10.57M
10.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.14M
28.14M
16.82M
16.82M
Operating expense
-8.52M
-8.52M
33.50M
33.50M
Total operating expenses
97.73M
97.73M
135.44M
135.44M
Operating income
83.61M
83.61M
48.71M
48.71M
Other non operating income
-84.00K
-84.00K
-118.50K
-118.50K
EBT including unusual items
73.63M
73.63M
46.85M
46.85M
EBT excluding unusual items
81.40M
81.40M
48.37M
48.37M
Income tax expense
4.08M
4.08M
5.44M
5.44M
Effective tax rate
5.55%
5.55%
11.61%
11.61%
Other operating expenses
-46.09M
-46.09M
6.11M
6.11M
Net income
69.55M
69.55M
41.42M
41.42M
Net profit margin
38.35%
38.35%
22.49%
22.49%
Earnings per share
-
-
-
-
Interest and investment income
236.00K
236.00K
80.00K
80.00K
Interest expense
-1.11M
-1.11M
-484.50K
-484.50K
Net interest expenses
-870.00K
-870.00K
-404.50K
-404.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
102.22M
102.22M
60.67M
60.67M
Gain or loss from assets sale
-25.58M
-25.58M
-4.03M
-4.03M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer